Faculty of Pharmaceutical Sciences

• Collaboration for Outcomes Research and Evaluation
• Molecular and Systems Pharmacology
• Nanomedicine and Chemical Biology
• Pharmacy Education Research and Leadership

By the Numbers

2025 QS World University Rankings, Pharmacy & Pharmacology: #38 Worldwide, #2 in Canada

As of Feb 2025 (from Jan 1, 2024 to Dec 31, 2024)

• Publications: 79
• Grants: 162
• Awards: 65
• Presentations: 61
• Media Hits: 148
• Students
  • E2P PharmD: 868 (2023 Winter Term 2); 647 (2024 Summer Term); 887 (2024 Winter Term 1)
  • Flex PharmD: 11 (2023 Winter Term 2); 6 (2024 Summer Term); 14 (2024 Winter Term 1)
  • BPSc: 189 (2023 Winter Term 2); 85 (2024 Summer Term); 245 (2024 Winter Term 1)
  • GDPL: N/A (2023 Winter Term 2); N/A (2024 Summer Term); 7 (2024 Winter Term 1)
  • MSc: 45
  • PhD: 50
  • Postdoctoral Research Fellows: 22
  • 16,000+ registrants in 52 Continuing Pharmacy Professional Development programs and 60 students in 3 Canadian Pharmacy Practice Program offerings
• Alumni (total): 7,737
• Experiential Education: 865 Practice Educators in 541 Practice Sites
• Practice: 2,057 Patient Encounters (Jan 1, 2024–Dec 31, 2024); 27,656 Patient Encounters (cumulative total through 134 months of operation)
• People: 84 Total FTE Faculty; 716 Clinical Faculty; 14 Honourary Faculty; 99 Total Staff; 4 Research Associates; 149 Student Workers

To view our 2024 Year in Review report, click here (PDF, 11.7 MB).

September 2025

NY Brittain, JA Finbloom. Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products. Adv. Drug Deliv. Rev. 2025, 225, 115663 https://www.sciencedirect.com/science/article/pii/S0169409X25001486

Schummers L, Norman WV. Viewpoint: In reproductive health policy and access, Canada is not the 51st US state. BMJ Sexual & Reproductive Health; 2025 Aug 27:bmjsrh-2025-202912. Available here: https://srh.bmj.com/content/early/2025/08/27/bmjsrh-2025-202912

Margaryan R, Sepehrvand N, Ouwerkerk W, Tromp J, Turgeon RD, Ezekowitz JA. Network meta-analysis of quality of life in heart failure with reduced ejection fraction. Circulation: Heart Failure 2025;[online]: https://doi.org/10.1161/CIRCHEARTFAILURE.125.013074

Cheng Vienna, Amiri Neda, Cheng Vicki, Ellis Ursula, Cragg Jacquelyn, Proulx Laurie, De Vera Mary. Pregnancy outcomes of non-Tumor Necrosis Factor inhibitor biologic disease-modifying antirheumatic drugs among individuals with autoimmune diseases: A scoping review and proposed framework for reporting outcomes. EULAR Rheumatology Open. 2025 August 8. doi: 10.1016/j.ero.2025.06.011. https://www.sciencedirect.com/science/article/pii/S3050708125000540

Turgeon RD, Van MT, Loewen P, Sadatsafavi M, Zhang W, MacDonald BJ, MacKay K, Hawkins N. Comparison of Quadruple Therapy Sequencing Strategies for Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc 2025;14:e042943. Available at: https://doi.org/10.1161/JAHA.125.042943

Margaryan R, Sepehrvand N, Ouwerkerk W, Tromp J, Turgeon RD, Ezekowitz JA. Network meta-analysis of quality of life in heart failure with reduced ejection fraction. Circulation: Heart Failure 2025;[online]: https://doi.org/10.1161/CIRCHEARTFAILURE.125.013074

Barry AR, Helisaz H, Safari A, Loewen PS. Effect of P2Y12 inhibitors on major adverse cardiovascular events after coronary artery bypass graft surgery: a population-based cohort study. Pharmacotherapy 2025;45(9):557–65. doi: https://doi.org/10.1002/phar.70047

Dhanoa T, Boswell R, Barry AR. Patients’ beliefs about their heart failure medications: a cross-sectional survey. Can J Hosp Pharm 2025;78(3):e3692. doi: https://doi.org/10.4212/cjhp.3692

Chan F, Lee J, Lu AH, Gokarn L, Rainkie D. Using simulation stethoscopes to support physical exam skill development in health professionals education: A scoping review of educational applications and outcomes. Currents in Pharmacy Teaching and Learning. 2025;17(12):102466. doi:10.1016/j.cptl.2025.102466. https://authors.elsevier.com/sd/article/S1877-1297(25)00187-X

Chen, L. P. C., Ng, C. N., Abdoulrezzak, R. M., Tsai, M., Hiebert, S., Manhas, J. K., Lai, T., & Tang, A. 2SLGBTQ+ patients’ experiences in the pharmacy in British Columbia, Canada. Canadian Pharmacists Journal. 2025;0(0). https://doi.org/10.1177/17151635251360227

Zed PJ, Loewen PS, Kapanan AI, Nemir A, Salil A. Pharmacists in Primary Care Network Program: Practice innovation in British Columbia. Can Pharm J (Ott) 2025;158:265–9. https://doi.org/10.1177/17151635251353242

Leung L, Min J, Wilbur K. Patients and Community Members as Equal Partners in Curriculum Decision-Making. Clin Teach. 2025;22(5):e70212. doi:10.1111/tct.70212

Chia-Yuan Chang CY, Nasreen S, Sadarangani M, Aquino K, Cragg JJ, Marra F. Effectiveness of vaccine dosing schedules for pneumococcal invasive disease in children: a meta-analysis. Vaccine X 2025; 27,100734, ISSN 2590–1362, https://doi.org/10.1016/j.jvacx.2025.100734

Marra F, Gomes, K, Liu E, Vadlamudi NK, Richardson K, Cragg JJ. Effects of herpes zoster infection, antivirals, and vaccination on risk of developing dementia: A systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 2025;21(1): https://doi.org/10.1080/21645515.2025.2546741

September 2025

Leung L, Martin B, Micallef J, Weir B, Tran A and student team. PD Med and Move Program. Parkinson Canada CARE Fund. $12,800.

2025–2026 Pharm Sci Postdoc Pathway to Independence Research Grant. Internal UBC Pharm Sci award to assist postdocs interested in applying for faculty research positions. This year's recipient is Dr. Gilciane Ceolin (supervisor Dr. Annalijn Conklin) with the project "Understanding inflammation as a mechanism linking healthy eating to mental health in older adults: a mediation study of the English Longitudinal Study of Ageing”. The grant is $10,000 for a 12 month period to support obtaining pilot data for their own independent research and future independent grant applications.